Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul 8;11(7):781.
doi: 10.3390/pathogens11070781.

Gut Microbiota Composition Associated with Clostridioides difficile Colonization and Infection

Affiliations
Review

Gut Microbiota Composition Associated with Clostridioides difficile Colonization and Infection

Elisa Martinez et al. Pathogens. .

Abstract

Clostridioides difficile is an anaerobic Gram-positive and spore-forming bacterium. The majority of C. difficile strains produce two toxins, A and B, associated with the development of acute diarrhea and/or colitis. In this review, two situations are distinguished: C. difficile infection (CDI) and asymptomatic colonization (AC). The main objective of this review is to explore the available data related to the link between the gut microbiota and the development of CDI. The secondary aim is to provide more information on why some people colonized with toxigenic C. difficile develop an infection while others show no signs of disease. Several factors, such as the use of antibiotics and proton pump inhibitors, hospitalization, and age, predispose individuals to C. difficile colonization and/or C. difficile infection. The gut microbiota of people with AC showed decreased abundances of Prevotella, Alistipes, Bacteroides, Bifidobacterium, Dorea, Coprococcus, and Roseburia. The gut microbiota of people suffering from CDI showed reductions in the abundances of Lachnospiraceae, Ruminococcaceae, Blautia spp., Prevotella spp., Dialister spp., Bifidobacterium spp., Roseburia spp., Anaerostipes spp., Faecalibacterium spp. and Coprococcus spp., in comparison with healthy people. Furthermore, increases in the abundances of Enterococcaceae and Enterococcus were associated with C. difficile infection.

Keywords: Clostridioides difficile; Clostridioides difficile infection; asymptomatic colonization; gut microbiota; human.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Box plot illustrating the mean relative proportion of C. difficile asymptomatic carriers in function of category of age. These data were found in articles that studied the prevalence of AC [4,20,21,22,23,24,25,26,27].

References

    1. Centers for Disease Control and Prevention (U.S.) Antibiotic Resistance Threats in the United States, 2019. Centers for Disease Control and Prevention; Atlanta, GA, USA: 2019.
    1. Colomb-Cotinat M., Assouvie L., Durand J., Daniau C., Leon L., Maugat S., Soing-Altrach S., Gateau C., Couturier J., Arnaud I., et al. Epidemiology of Clostridioides difficile infections, France, 2010 to 2017. Eurosurveillance. 2019;24:1800638. doi: 10.2807/1560-7917.ES.2019.24.35.1800638. - DOI - PMC - PubMed
    1. European Centre for Disease Prevention and Control . Annual Epidemiological Report for 2016. ECDC; Stockholm, Sweden: 2018. Healthcare-associated infections: Clostridium difficile infections.
    1. Furuya-Kanamori L., Marquess J., Yakob L., Riley T.V., Paterson D.L., Foster N.F., Huber C.A., Clements A.C.A. Asymptomatic Clostridium difficile colonization: Epidemiology and clinical implications. BMC Infect. Dis. 2015;15:516. doi: 10.1186/s12879-015-1258-4. - DOI - PMC - PubMed
    1. D’Silva K.M., Mehta R., Mitchell M., Lee T.C., Singhal V., Wilson M.G., McDonald E.G. Proton pump inhibitor use and risk for recurrent Clostridioides difficile infection: A systematic review and meta-analysis. Clin. Microbiol. Infect. 2021;27:697–703. doi: 10.1016/j.cmi.2021.01.008. - DOI - PubMed